kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - autres agents antinéoplasiques - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.
aethoxysklerol 0,5 % sol. inj. i.v. amp.
chemische fabrik kreussler & co gmbh - polidocanol/lauromacrogol 10 mg/2 mg - solution injectable - 0,5 % - lauromacrogol 400 10 mg - polidocanol
aethoxysklerol 2 % sol. inj. i.v. amp.
chemische fabrik kreussler & co gmbh - polidocanol/lauromacrogol 40 mg/2 mg - solution injectable - 2 % - lauromacrogol 400 40 mg - polidocanol
aethoxysklerol 1 % sol. inj. i.v. amp.
chemische fabrik kreussler & co gmbh - polidocanol/lauromacrogol 20 mg/2 mg - solution injectable - 1 % - lauromacrogol 400 20 mg - polidocanol
aethoxysklerol 3 % sol. inj. i.v. amp.
chemische fabrik kreussler & co gmbh - polidocanol/lauromacrogol 60 mg/2 mg - solution injectable - 3 % - lauromacrogol 400 60 mg - polidocanol
fluoresceine 10 % faure sol. inj. i.v. amp.
serb sa-nv - fluorescéine sodique 100 mg/ml - solution injectable - fluorescéine sodique 100 mg/ml - fluorescein
fluracedyl 50 mg/ml sol. inj. i.artér./i.v. flac.
teva pharma belgium sa-nv - fluorouracil 1000 mg/20 ml - solution injectable - 50 mg/ml - fluorouracil 1000 mg - fluorouracil
fluracedyl 50 mg/ml sol. inj. i.artér./i.v. flac.
teva pharma belgium sa-nv - fluorouracil 1000 mg/20 ml - solution injectable - 50 mg/ml - fluorouracil 5000 mg - fluorouracil
nestrolan 100 mg comp.
amophar s.p.r.l.-b.v.b.a. - chlorhydrate de trazodone 100 mg - comprimé - 100 mg - chlorhydrate de trazodone 100 mg - trazodone
omnipaque 350 mg i/ml sol. inj. i.artér./i.v./i.théc. flac.
ge healthcare bv-srl - iohexol 755 mg/ml - solution injectable - 350 mg i/ml - iohexol 755 mg/ml - iohexol